Kyoto Prefectural University of Medicine, Japan
Papers describe findings from Kyoto Prefectural University of Medicine, Japan, studies
Published in Pharma Law Weekly, January 16th, 2007
This trend article about Kyoto Prefectural University of Medicine, Japan, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: The combination of sulforaphane (SFN) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) could potentially treat osteosarcoma.
"SFN, a naturally occurring isothiocyanate, is an attractive agent because of its potent anticancer effects. SFN suppresses the proliferation of various cancer cells in vitro and in vivo. TRAIL is also one of the most promising candidates for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2007-01-16)
More Articles from Pharma Law Weekly
- Behavior
Research from Creighton University, Department of Psychology provides new data on behavior - Healthcare Policy
American Physical Therapy Association applauds signing of HR 6111 - Healthcare Policy
ASA applauds President Bush's signing of Combating Autism Act - Healthcare Policy
Emergent BioSolutions applauds passage and signing of BARDA legislation - Legal Issues
Candela files patent infringement action against Palomar Medical Technologies in Lufkin, Texas - Legal Issues
Motley Rice files suit against manufacturer of failed hernia repair patch - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
